info icon

This is a non-core endpoint: only basic statistics are computed.

Benign neoplasm: Pineal gland

CD2_BENIGN_PINEAL_EXALLC

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

None

-

2. Check conditions

None

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 D35.4&
  • Hospital discharge: ICD-9 2274
  • Hospital discharge: ICD-8 2263
  • Cause of death: ICD-10 D35.4&
  • Cause of death: ICD-9 2274
  • Cause of death: ICD-8 2263

2 out of 7 registries used, show all original rules.

-

4. Check minimum number of events

None

-

5. Include endpoints

None

-

6. Filter based on genotype QC (FinnGen only)

None

-

Control definitions (FinnGen only)

Control exclude
C3_CANCER, C3_CANCER_WIDE

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
D35
Name in latin
Neoplasma benignum corporis pinealis

Case counts by codes

FinnGen case counts by registry codes:

No upset plot: script not run.

No upset table: script not run.

Summary Statistics

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 82 61 21
Unadjusted period prevalence (%) 0.02 0.02 0.01
Median age at first event (years) 36.89 35.46 41.04

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
76
Matched controls
761
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D35.4
ICD-10 Finland
Benign neoplasm: Pineal gland
+∞
101.4
73
*
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
10.0
9.9
20
26
G93.0
ICD-10 Finland
Cerebral cysts
56.8
8.9
10
*
AAB00
NOMESCO Finland
Extirpation of intracranial lesion
100.8
8.6
9
*
R51.80
ICD-10 Finland
Headache
5.3
8.3
28
75
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
7.5
6.6
15
24

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
31
156
2.59
3.94
3.5
5.6
1.0
1.1
inr
—
8
49
6
5
12.79
3.82
1.0
1.8
—
—
—
0
0
66
483
2.88
3.67
3.4
3.6
7.7
8.6
mm/h
0.35
59
449
26
127
2.53
3.46
1.9
1.8
0.6
1.0
mg/l
0.48
20
94
8
14
6.20
3.43
7.1
8.4
91.7
94.2
%
—
8
14
8
14
6.20
3.43
1.0
1.4
—
—
—
0
0
6
7
9.12
3.32
1.0
1.4
—
—
—
0
0
7
12
6.26
3.09
1.0
1.3
—
—
—
0
0
7
13
5.77
2.93
1.4
1.1
—
—
—
0
0
7
14
5.35
2.79
7.7
8.1
0.9
0.8
%
—
7
14
7
14
5.35
2.79
7.9
8.1
2.1
1.4
%
—
7
14
6
10
6.37
2.75
1.0
1.2
—
—
—
0
0
23
122
2.23
2.48
3.1
2.7
—
—
—
0
0
13
54
2.67
2.33
1.2
1.0
—
—
—
0
0
74
633
2.73
2.33
5.3
4.5
1.6
1.7
mu/l
0.46
65
594
65
528
2.11
2.01
4.7
4.1
14.6
14.5
pmol/l
0.18
57
492
5
11
4.76
1.97
11.0
2.5
1.4
1.2
mmol/l
—
5
11
29
182
1.92
1.97
3.7
2.8
11.5
21.4
ng/l
0.80
14
86
9
34
2.85
1.93
8.9
5.1
1.5
1.5
mmol/l
—
9
23
5
12
4.36
1.85
1.0
1.1
—
—
—
0
0
6
20
3.15
1.61
10.7
2.6
—
—
—
0
0
24
151
1.83
1.58
3.5
1.8
2.4
2.4
mmol/l
0.89
19
132
9
38
2.53
1.51
2.2
4.1
—
—
—
0
0
33
235
1.68
1.41
1.8
1.6
—
—
—
0
0
9
42
2.28
1.39
3.1
2.3
—
—
—
0
0
5
17
3.06
1.38
10.8
2.4
—
—
—
0
0
17
100
1.88
1.36
4.2
2.8
—
—
—
0
0
5
19
2.73
1.23
2.0
1.9
—
—
—
0
0
12
65
1.99
1.21
1.7
2.2
15.8
15.3
umol/l
0.10
12
59
74
672
2.04
1.18
11.4
9.9
39.0
40.5
%
0.59
58
563
49
399
1.57
1.14
2.8
2.7
—
—
—
0
0
9
48
1.98
1.04
8.1
5.4
1.1
1.0
mmol/l
—
9
43
26
187
1.57
1.03
1.9
1.8
—
—
—
0
0
6
27
2.32
0.95
2.3
6.4
—
—
—
0
0
27
202
1.50
0.88
1.4
1.6
109.6
94.2
pmol/l
0.51
12
107
6
32
1.94
0.83
1.8
3.2
4.0
4.3
kpa
—
6
32
23
169
1.50
0.81
1.2
1.3
2.3
2.2
g/l
0.09
15
107
44
367
1.43
0.81
6.9
7.6
4.2
3.9
e9/l
0.50
39
322
40
328
1.43
0.81
6.1
4.4
0.0
0.0
estimate
—
9
68
29
224
1.46
0.81
4.2
2.8
151.3
37.3
e6/l
0.48
23
144
0
25
0.00
0.80
0.0
2.6
—
5.2
—
0
12
5
23
2.25
0.77
1.8
3.1
134.0
133.9
g/l
—
5
23
5
23
2.25
0.77
4.4
13.5
—
—
—
0
0
7
39
1.87
0.75
1.9
3.6
—
—
—
0
0
7
41
1.77
0.72
2.6
2.5
—
—
—
0
0
40
334
1.39
0.71
5.2
3.3
0.0
0.0
estimate
—
9
69
16
114
1.50
0.65
3.3
2.1
134.6
79.5
ug/g
0.35
11
88
14
194
0.66
0.65
1.4
1.8
—
—
—
0
0
14
98
1.52
0.61
1.1
1.6
452.1
463.7
pmol/l
0.04
14
85
24
188
1.39
0.61
6.9
6.1
—
—
—
0
0
21
161
1.41
0.60
3.5
2.4
—
—
—
0
0
18
134
1.44
0.59
1.6
1.7
2.2
2.7
mg/l
0.74
18
114
8
54
1.53
0.59
9.3
3.2
—
—
—
0
0
68
630
1.46
0.58
3.7
3.3
5.6
5.7
mmol/l
0.46
60
584
15
109
1.46
0.56
1.5
1.5
—
—
—
0
0
6
40
1.54
0.53
2.0
3.5
5.8
5.9
kpa
—
6
40
19
149
1.36
0.47
3.8
2.4
7.4
7.4
ph
—
5
23
13
97
1.40
0.42
2.9
2.3
—
—
—
0
0
0
17
0.00
0.41
0.0
1.3
—
—
—
0
0
0
17
0.00
0.41
0.0
2.1
—
—
—
0
0
9
65
1.43
0.40
3.6
1.8
3.7
6.1
umol/l
—
9
54
9
66
1.41
0.40
1.4
2.2
—
—
—
0
0
9
67
1.39
0.40
1.3
2.1
27.0
30.1
s
—
9
67
5
36
1.41
0.39
1.6
1.8
—
—
—
0
0
6
45
1.36
0.34
2.8
2.0
—
—
—
0
0
7
51
1.41
0.32
1.0
1.1
—
—
—
0
0
10
75
1.38
0.32
1.1
1.1
—
—
—
0
0
21
178
1.24
0.30
7.0
3.4
0.0
0.0
estimate
—
9
67
15
122
1.28
0.29
1.1
1.6
—
—
—
0
0
18
151
1.25
0.28
7.9
5.9
—
—
—
0
0
8
66
1.23
0.28
1.5
1.6
—
—
—
0
0
63
659
0.81
0.27
4.1
3.3
1.6
1.5
mmol/l
0.71
58
625
9
72
1.28
0.27
1.1
1.2
—
—
—
0
0
25
219
1.20
0.26
1.2
1.8
—
—
—
0
0
21
182
1.21
0.24
4.4
2.4
—
—
—
0
0
5
39
1.30
0.23
1.6
1.4
—
—
—
0
0
36
330
1.16
0.22
5.3
3.1
0.0
0.0
estimate
—
9
69
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
6
50
1.22
0.20
4.5
3.0
4.2
4.2
e9/l
—
6
45
22
246
0.86
0.20
1.6
1.7
—
—
—
0
0
18
157
1.19
0.19
5.1
2.9
—
—
—
0
0
7
58
1.23
0.19
1.6
1.6
—
—
—
0
0
24
265
0.87
0.18
2.6
2.3
—
—
—
0
0
8
68
1.20
0.17
1.1
1.4
—
—
—
0
0
8
69
1.18
0.17
1.6
1.6
—
—
—
0
0
8
69
1.18
0.17
1.6
1.5
—
—
—
0
0
8
69
1.18
0.17
1.6
1.6
—
—
—
0
0
8
70
1.16
0.17
1.0
1.6
—
—
—
0
0
8
70
1.16
0.17
1.8
1.5
—
—
—
0
0
21
188
1.16
0.17
4.5
2.8
—
—
—
0
0
21
190
1.14
0.14
1.0
1.3
0.6
1.3
u/ml
—
7
54
25
271
0.89
0.14
5.0
2.8
—
—
—
0
0
9
108
0.81
0.14
1.3
1.3
—
—
—
0
0
49
469
1.11
0.13
5.9
3.9
—
—
—
0
0
62
601
1.13
0.13
15.6
11.2
13.3
13.4
%
0.29
62
594
5
46
1.09
0.10
1.4
2.1
—
—
—
0
0
65
664
0.90
0.09
4.1
3.4
4.9
4.8
mmol/l
0.79
60
630
18
166
1.11
0.08
4.8
4.7
—
—
—
0
0
7
68
1.03
0.08
1.4
1.4
—
—
—
0
0
11
121
0.90
0.06
1.3
1.2
2.2
6.2
u/ml
—
5
49
14
131
1.08
0.04
8.1
3.0
110.4
74.1
mg/l
—
9
85
45
441
1.05
0.03
6.9
3.7
—
44.9
—
0
7
28
272
1.04
0.02
1.5
2.2
—
—
—
0
0
14
137
1.03
0.00
9.5
3.9
34.1
9.6
mg/mmol
—
9
88
67
667
1.02
0.00
4.2
3.6
2.9
2.9
mmol/l
0.03
61
631
29
294
0.98
0.00
13.9
6.7
0.0
0.0
e9/l
0.00
24
242
6
61
0.98
0.00
1.7
1.5
—
—
—
0
0
5
56
0.89
0.00
1.6
1.4
—
—
—
0
0
0
5
0.00
0.00
0.0
7.6
—
10.4
—
0
5
0
9
0.00
0.00
0.0
2.7
—
4.0
—
0
9
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
0
9
0.00
0.00
0.0
2.7
—
105.7
—
0
9
5
59
0.84
0.00
1.6
1.4
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
2.7
—
—
—
0
0
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
6
59
1.02
0.00
1.5
1.4
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
0
7
0.00
0.00
0.0
1.1
—
282.3
—
0
7
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0

Mortality – FinRegistry

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

Index endpoint: CD2_BENIGN_PINEAL_EXALLC – Benign neoplasm: Pineal gland

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).